Dr. Reddy's Laboratories reports Rs. 19.8 Cr PAT in Q3FY21
The company has posted net profit of Rs.19.8 crores for the period ended December 31, 2020 as against net loss of Rs. 569.7 crores for the period ended December 31, 2019.
The company has posted net profit of Rs.19.8 crores for the period ended December 31, 2020 as against net loss of Rs. 569.7 crores for the period ended December 31, 2019.
The commercial production in the SML was started in November 1989.
The phase 3 clinical trial of Sputnik V will be conducted on 1,500 subjects as part of the randomized, double blind, parallel group placebo controlled study in India.
The Phase 2 study of Sputnik V was conducted on 100 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
Their feedback and the consequent changes in software/protocols based on those inputs were deliberated upon.
The new centre marks a significant milestone in Merck's India operations, reinforcing the company's commitment to building a more connected, agile, and future-ready digital enterprise
With access to over 1,500 healthcare products and savings of up to 90%compared to conventional market prices, the platform aims to help consumers reduce their healthcare expenses
The collaboration brings together expertise in healthcare and early education to support children during their formative years and empower parents with evidence-based guidance
The initiative enables users to convert unstructured medical records into standardized digital health profiles while supporting interoperability under the Ayushman Bharat Digital Mission
The proposed joint venture will accelerate the launch of pharmaceutical and consumer healthcare products across South-East Asia, the Middle East, Africa, and other emerging markets
Subscribe To Our Newsletter & Stay Updated